These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 23992264

  • 1. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI, Mohd Ashari NS, Mohd Daud K, Che Husin CM.
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [Abstract] [Full Text] [Related]

  • 4. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 13; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 6. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 13; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 13; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 8. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M.
    Arthritis Rheum; 2012 Nov 13; 64(11):3706-14. PubMed ID: 22740328
    [Abstract] [Full Text] [Related]

  • 9. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.
    Arthritis Rheum; 2012 Apr 13; 64(4):1227-36. PubMed ID: 22238051
    [Abstract] [Full Text] [Related]

  • 10. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec 13; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

  • 11. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 13; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 12. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC, Wang CR, Liu MF, Chen FF, Liang CC.
    Asian Pac J Allergy Immunol; 2002 Dec 13; 20(4):223-7. PubMed ID: 12744622
    [Abstract] [Full Text] [Related]

  • 13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Dec 13; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.
    Lupus; 2012 Jan 13; 21(1):36-42. PubMed ID: 21993384
    [Abstract] [Full Text] [Related]

  • 15. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug 13; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C.
    Rom J Intern Med; 2010 Aug 13; 48(2):159-63. PubMed ID: 21428180
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M.
    J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280
    [Abstract] [Full Text] [Related]

  • 20. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S, Vanhecke D, Trendelenburg M.
    Clin Immunol; 2015 Oct 01; 160(2):180-7. PubMed ID: 26148903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.